Nasal CPAP has become an indispensable part of the primary treatment of newborns with respiratory distress syndrome

Acta Paediatr. 2007 Apr;96(4):482-4. doi: 10.1111/j.1651-2227.2007.00263.x.


Prenatal steroids, early nasal CPAP combined with early surfactant treatment followed by extubation to nasal CPAP, and if necessary mechanical ventilation is a very effective treatment of respiratory distress syndrome. This treatment package is part of the 'Scandinavian model' for treatment of very-low-birthweight infants which also comprises gentle ventilation at birth; minimal handling; 'neonatal individualized development care and assessment program'; high priority of breast feeding; and use of kangaroo method and which facilitates observation and nursing of sick premature infants and optimizes the possibility for early mother-child contact. The incidence of bronchopulmonary dysplasia seems to be less of a problem in centres preferring nasal CPAP as the primary treatment for respiratory distress syndrome.

MeSH terms

  • Bronchopulmonary Dysplasia / prevention & control
  • Continuous Positive Airway Pressure*
  • Humans
  • Infant, Newborn
  • Respiratory Distress Syndrome, Newborn / therapy*